KLBF:IDX
Kalbe Farma Tbk PT
IDR 780.00
arrow_upward
+1.96%(+15.00) 1D
Oct 13, 4:12:15 PM GMT+7 · IDR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for KLBF...
Open
IDR 770
High
IDR 780
Low
IDR 755
Mkt. cap
36.51T
Avg. vol.
66.50M
Volume
37.55M
Dividend
2.56%
Quarterly dividend
IDR 5
Ex-dividend date
Jun 4, 2026
P/E ratio
9.80
52-wk high
IDR 1,345
52-wk low
IDR 630
EPS
IDR 80
Shares outstanding
46.81B
No. of employees
13K
Open
IDR 770
High
IDR 780
Low
IDR 755
Mkt. cap
36.51T
Avg. vol.
66.50M
Volume
37.55M
Dividend
2.56%
Quarterly dividend
IDR 5
Ex-dividend date
Jun 4, 2026
P/E ratio
9.80
52-wk high
IDR 1,345
52-wk low
IDR 630
EPS
IDR 80
Shares outstanding
46.81B
No. of employees
13K
News stories
From web sources and news partners
Benzinga
·
52 minutes ago
VERAXA Biotech (NASDAQ: VRXA) Presents First In Vivo Proof-of-Concept Data for BiTAC-ADC Platform at Worl
Stock Titan
·
1 hour ago
Nasdaq files to remove Bone Biologics (Nasdaq: BBLG) warrants from listing and/or registration.
Yahoo Finance
·
32 minutes ago
XRP Fell 8% in the Week It Got a Nasdaq Listing, a Dubai Bank Deal and an ETF Inflow. Why Did None of It Count?
CNBC
·
1 hour ago
Opening Bell: October 13 2026
Profile
PT Kalbe Farma Tbk, or simply known as Kalbe, is an Indonesian pharmaceutical, healthcare and nutrition company established in 1966. The company has expanded by strategic acquisitions of pharmaceutical companies, becoming an integrated consumer health and nutrition enterprise.
The Kalbe Group has brands in the prescription drugs, OTC drugs, energy drink and nutrition products, with a distribution arm that reaches over one million outlets. Notably, the company produces misoprostol, a drug which is used to treat stomach ulcers but is also widely used in Indonesia as an illegal abortifacient.
Company brands in healthcare and pharmaceutical segments include Promag, Mixagrip, Woods, Komix, Diabetasol, Prenagen, Extra Joss and Fitbar.
Kalbe is the largest publicly listed pharmaceutical company in Southeast Asia with around US$5 billion in market capitalization and revenues of over Rp 15 trillion. The name "Kalbe" is a syllabic abbreviation of its founder's name: Khouw Lip Boen. Wikipedia
About Kalbe Farma Tbk PT